A randomised controlled trial of fludarabine/cyclophosphomide combination with or without rituximab in patients with untreated mantle cell lymphoma.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Fludarabine; Rituximab
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 04 May 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record).
- 26 Mar 2011 Planned end date changed from 1 Sep 2010 to 2 Dec 2010 as reported by United Kingdom Clinical Research Network.